Dedimo
Dedimo is a Dutch mental healthcare holding founded in 2020 that operates five specialized subsidiaries — adult ADHD, youth ADHD, insurance-medicine examinations, ARBO reintegration, and neurodiversity workplace consulting — reimbursed primarily through Dutch health insurance and employer channels, supported by a central staff and in-house R&D unit.
- Company typePrivate
- Founded2020
- HeadquartersUtrecht, Netherlands
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Dedimo does
Dedimo B.V. is a privately held Dutch mental healthcare holding company founded in 2020 and headquartered at Janskerkhof 16 in Utrecht. It operates a portfolio of five wholly-owned, specialized healthcare subsidiaries — ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (ADHD care for children and adolescents), WPEX (psychiatric, neuropsychological and insurance-medicine expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under the ARBO occupational-health framework), and The Brain Hub (organizational consulting to help employers support neurodivergent employees). The portfolio is supported by a central staff function covering HR, finance, IT, operations, marketing, recruiting, quality systems and data science, and by an in-house Research & Development unit that conducts scientific research on treatment effectiveness and develops custom ICT applications to support care processes. The company is led by a four-person executive board — CEO Jan Willem Peterse, CFO Michiel de Jong, and Director of Innovation & Strategy Jan-Eidse van Melle — with no disclosed external investors, funding rounds, or parent company.
The business operates as a B2B2C healthcare services provider. Patient access comes through Dutch GP referrals, mandatory health-insurance (zorgverzekering) reimbursement for clinical services, and employer/ARBO channels for occupational-health and reintegration work. Patient-facing subsidiaries offer combined in-person and video consultations; employer-facing subsidiaries (WPEX, QSG, The Brain Hub) distribute through employer relationships, occupational-health insurers, and insurance-medicine channels. Pricing is not publicly disclosed and services are reimbursed primarily via the Dutch mandatory health-insurance system. Revenue mechanics are therefore recurring and reimbursement-driven rather than transactional. Geographic scope is the Netherlands only, with no international expansion disclosed.
The technology layer is internal and proprietary but not publicly detailed: Dedimo R&D develops custom ICT applications to optimize care pathways and protocol effectiveness, supported by a small in-house data-science team. No APIs, SDKs, third-party AI integrations, or patents are disclosed. The central staff model — combining HR, finance, IT, marketing, data science, quality systems and R&D across five clinical brands — is the company's principal operating asset and supports both cost sharing across subsidiaries and a continuous-improvement loop on treatment protocols.
Dedimo firmographics
Firmographics- Name
- Dedimo
- Legal name
- Dedimo B.V.
- Website
- https://dedimo.nl
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Dedimo is a Dutch mental healthcare holding founded in 2020 that operates five specialized subsidiaries — adult ADHD, youth ADHD, insurance-medicine examinations, ARBO reintegration, and neurodiversity workplace consulting — reimbursed primarily through Dutch health insurance and employer channels, supported by a central staff and in-house R&D unit.
- Ownership category
- akta.pro rank
Dedimo industry classification
Industry- Product category
- Mental Healthcare Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)
- akta.pro secondary industries
- Psychiatry & Medication Management Platforms (HLALAEAB), Behavioral Health & Psychiatry Virtual Care (Payer Network) (HLALACAC)
Keywords
Where Dedimo is headquartered
LocationHeadquarters
- HQ city
- Utrecht
- HQ country
- Netherlands
- HQ region
- Europe
Offices2 records
Markets served
Dedimo business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Mental Healthcare Services Revenue: Dedimo generates revenue through the delivery of mental healthcare services across its five subsidiary brands. Services are reimbursed through Dutch health insurance (zorgverzekering) and occupational health (ARBO) channels. The portfolio covers ADHD diagnosis/treatment for adults and youth, psychiatric assessments, psychological absenteeism diagnosis/treatment/reintegration, and neurodivergent workplace support.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Dedimo product offering
Product offeringCore offering
Dedimo is a Dutch healthcare innovation company operating a portfolio of five specialized mental healthcare subsidiaries: ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (youth ADHD diagnosis and treatment), WPEX (psychiatric neuropsychological and insurance medical expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under ARBO frameworks), and The Brain Hub (neurodivergent workplace transformation consulting). Services are delivered through specialized clinics supported by a central staff providing HR, finance, ICT, marketing, data science, and R&D functions.
Product overview
Dedimo is a portfolio company comprising five mental healthcare initiatives, established in 2020. The portfolio includes ADHDcentraal (adult ADHD treatment), ADHDcentraal Jeugd (youth ADHD treatment), WPEX (psychiatric neuropsychological examinations), QSG (psychological absenteeism reintegration), and The Brain Hub (neurodiversity workplace support). These initiatives are centrally supported by Dedimo Central Staff (HR, finance, operations, marketing, ICT, data science) and Dedimo Research & Development, which conducts scientific research and develops ICT applications to optimize care processes.
Differentiator
Problem solved
Functional benefit
Products and services
- ADHDcentraal Knowledge and treatment center for ADHD in adults, providing specialized psychiatric care, diagnosis, and treatment services. Targets adult patients seeking ADHD assessment and ongoing care, with combined in-person and video consultation options.
- ADHDcentraal Jeugd Knowledge and treatment center for AD(H)D in children and adolescents, offering specialized youth mental health services with family-centered care and combined consultation options to minimize disruption.
- WPEX Provides psychiatric, neuropsychological, and insurance medical expert examinations for employers, occupational health services, and insurance companies. Supports objective expert assessments required for occupational health decisions and insurance claims.
- QSG Provides diagnosis, treatment, and reintegration services for employees with psychological absenteeism under ARBO (occupational health) frameworks. Helps employers reduce absenteeism costs and comply with occupational health regulations.
- The Brain Hub Helps employees with neurodivergent brains excel by guiding organizations through transformation toward a healthy and inclusive work environment. Provides consulting on organizational change, neurodivergent employee retention, and inclusive workplace culture.
Quantifiable outcome
- Minimized patient wait times
Companies that use Dedimo
Customer profileSegments5 records
Ideal customer profiles5 records
Dedimo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Dedimo partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Institutions and Universities (unnamed)minorDedimo R&D collaborates with external institutions and universities on research projects, supporting the individual subsidiaries' research objectives and contributing to product development. Specific partner names and dates are not publicly disclosed.
Scale indicators2 records
Recent moves7 records
Expansion highlights6 records
Dedimo competitors and assessment
Company assessmentOthers
- Karify: Dutch digital mental health platform providing e-mental health tools and patient-clinician portals to GGZ providers. Comparable to Dedimo R&D's custom ICT applications and Dedimo's broader digital health tooling strategy, as an enabling technology peer rather than direct clinical competitor.
Broad incumbents
- ArboNed: Largest Dutch ARBO/occupational health service provider, part of HumanTotalCare. Directly comparable to Dedimo's QSG psychological absenteeism reintegration and The Brain Hub workplace neurodiversity consulting via the same employer/ARBO channel.
- PsyQ: Largest Dutch chain of mental healthcare clinics, part of Parnassia Groep, offering specialized outpatient GGZ across multiple conditions. Comparable to Dedimo as a Netherlands-based specialty mental healthcare operator, though with broader condition coverage and larger scale.
- Headspace Health: Global digital mental health platform combining meditation, coaching and therapy. Comparable to Dedimo's employer-facing The Brain Hub and broader mental healthcare portfolio, though at much larger scale and B2B employer-first go-to-market.
Emerging players
- Talkspace: US telehealth platform offering therapy and psychiatry via video/text to insurers and employers. Comparable to Dedimo's hybrid mental healthcare delivery model and payer-channel revenue structure, though operating in the US market.
- OpenUp: European digital mental health platform serving employers and employees across multiple countries. Comparable to Dedimo's The Brain Hub B2B employer channel and ADHDcentraal's digital-first delivery model, though operating pan-Europe rather than Netherlands-only.
- Lyra Health: US mental health benefits platform for employers offering therapy, coaching and psychiatry. Comparable to Dedimo's The Brain Hub and QSG B2B employer services targeting workplace mental health and absenteeism reduction.
Direct peers
- Interapy: Dutch online therapy provider offering reimbursed mental healthcare through internet-based protocols. Comparable to Dedimo's ADHDcentraal and QSG lines via the same Dutch health-insurance reimbursement channel and behavioral therapy focus.
- Mindler: Swedish-founded digital mental health platform that operates in the Netherlands, offering video-based therapy and psychiatry with insurance reimbursement. Directly comparable to Dedimo's hybrid in-person + video mental health delivery model.
- iPractice: Dutch psychology practice network offering online and in-person mental healthcare reimbursed by Dutch insurers. Comparable to ADHDcentraal and ADHDcentraal Jeugd as a reimbursed outpatient mental healthcare provider in the Netherlands.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Dedimo social profiles
Digital presenceDedimo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dedimo leadership team
Management profileNumber of profiles
Profiles8 records
Dedimo subsidiaries and ownership
Company hierarchySubsidiaries5 records
Dedimo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dedimo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dedimo
What does Dedimo do?
Dedimo is a Dutch healthcare innovation company operating a portfolio of five specialized mental healthcare subsidiaries: ADHDcentraal (adult ADHD diagnosis and treatment), ADHDcentraal Jeugd (youth ADHD diagnosis and treatment), WPEX (psychiatric neuropsychological and insurance medical expert examinations), QSG (diagnosis, treatment and reintegration for psychological absenteeism under ARBO frameworks), and The Brain Hub (neurodivergent workplace transformation consulting). Services are delivered through specialized clinics supported by a central staff providing HR, finance, ICT, marketing, data science, and R&D functions.
Is Dedimo a public or private company?
Dedimo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Dedimo founded?
Dedimo was founded in 2020. It employs 11 to 50 people.
Where is Dedimo based?
Dedimo is headquartered in Utrecht, Netherlands, in the Europe region.
How does Dedimo make money?
One revenue line is on record: mental Healthcare Services Revenue.
Who are Dedimo's main competitors?
Karify is listed as an others. Broad incumbents are ArboNed, PsyQ and Headspace Health. Emerging players are Talkspace, OpenUp and Lyra Health. Direct peers are Interapy, Mindler and iPractice.
Does Dedimo have an API?
No public API is recorded for Dedimo.
What industry is Dedimo in?
Dedimo's product category is Mental Healthcare Services. Its primary akta.pro industry code is HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching), with a secondary code of HLALAEAB, Psychiatry & Medication Management Platforms. Its NAICS code is 621112 and its SIC code is 8011.